Skip to content

Donate

  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2023
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Healthe-rnd
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • 2025 Conference | Romania
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us
  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2023
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Healthe-rnd
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • 2025 Conference | Romania
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us
Menu here

DAY 3

  • Serena Hung, Senior Director at Wave Life Sciences giving an introduction to the biotechnology company's huntingtin lowering approach.
  • Associate Director at uniQure, Melvin Evers, speaking about gene therapy and Huntington's disease.
  • Panel discussion. Left to right: Baltazar Gomez (Novartis), Melvin Evers (uniQure), Scott Schobel (Roche Pharmaceuticals), Serena Hung (Wave Life Sciences) and Ralf Reilmann.
  • Left to right: Baltazar Gomez (Novartis), Melvin Evers (uniQure), Scott Schobel (Roche Pharmaceuticals) and Serena Hung (Wave Life Sciences)
  • Winning photo of EHA and Orphan People Russia's photo exhibition.
  • An amazing group of people coming all the way from Portugal!
  • Goodbye hugs.
  • Naim from Turkey at his first (but not last) Huntington's disease conference.
  • Left to right: Valerie Pihet, Naim and Alice Rivieres.
  • Left to right: Matty Ellison, Valerie Pihet, Naim and Alice Rivieres.
  • Attendees from Romania.
  • Attendees from Romania.

MENU

MENU

  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2023
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Healthe-rnd
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • 2025 Conference | Romania
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.